Cell No. : Cell Name
RCB3547 : Sez627(+)
update : 2024/10/02
|
Comment | BSL2. Currently not ready. We don't know whether virus particles are produced or not. Therefore, the cells must be handled under BSL2. |
Comment from the depositor | Sezary syndrome like patient derived T cell line (IL-2 dependent). |
Terms and conditions | |
Remarks | |
Order Form |
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Expected time |
Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
|
|
BSL |
BSL2
|
Cellosaurus(Expasy) |
CVCL_5364
|
Reference information |
Reference |
3
|
User's Publication |
0
|
Reference |
2761
K Nosaka, M Maeda, S Tamiya, T Sakai, H Mitsuya, M Matsuoka
Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia
Cancer Res
2000
60(4):1043-8
PubMed ID: 10706122
|
2510
Maeda M, Noma T, Hama K, Honjo T.
Application of a human T cell line derived from a Sézary syndrome patient for human interleukin 4 assay
Immunol Lett
1988
18(4):247-53
PubMed ID: 3263317
DOI: 10.1016/0165-2478(88)90170-8
|
3090
S Namiuchi, S Kumagai, H Sano, J Yodoi, T Uchiyama, K Ikai, H Imura, M Maeda
A human T cell line established from a patient with Sézary syndrome. Application for assay of human interleukin 2 (IL-2)
J Immunol Methods
1986
94(1-2):215-24
PubMed ID: 3023492
DOI: 10.1016/0022-1759(86)90236-x
|